Showing results (21-30 of 111) with videos related to
Sort By:
Pageof 12
Expert Opinion on Biological Therapy|March 1, 2025
Drawing on collective action theory to foster sustainable biosimilar markets - insights from co-creation workshops with UK and Belgian stakeholdersTeresa Barcina Lacosta, Arnold G Vulto, Florian Turk, et al.Frontiers in Pharmacology|June 17, 2017
Adoption of Biosimilar Infliximab for Rheumatoid Arthritis, Ankylosing Spondylitis, and Inflammatory Bowel Diseases in the EU5: A Budget Impact Analysis Using a Delphi PanelTim A Kanters, Jelena Stevanovic, Isabelle Huys, et al.Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|February 26, 2024
Can Endangered Biosimilar Markets be Rescued? The Need to Bridge Competing Interests for Long-Term GainTeresa Barcina Lacosta, Arnold G Vulto, Florian Turk, et al.Pharmaceuticals (Basel, Switzerland)|February 9, 2021
Informing Patients about Biosimilar Medicines: The Role of European Patient AssociationsYannick Vandenplas, Steven Simoens, Philippe Van Wilder, et al.Health Research Policy and Systems|July 6, 2023
The impact of policy interventions to promote the uptake of biosimilar medicines in Belgium: a nationwide interrupted time series analysisYannick Vandenplas, Steven Simoens, Philippe Van Wilder, et al.Frontiers in Pharmacology|May 8, 2023
Biosimilar competition in European markets of TNF-alpha inhibitors: a comparative analysis of pricing, market share and utilization trendsElif Car, Arnold G Vulto, Mark Van Houdenhoven, et al.Frontiers in Pharmacology|May 6, 2021
Off-Patent Biological and Biosimilar Medicines in Belgium: A Market Landscape AnalysisYannick Vandenplas, Steven Simoens, Philippe Van Wilder, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 20, 2006
Renal extraction of cystatin C vs 125I-iothalamate in hypertensive patientsLyonne K van Rossum, Robert Zietse, Arnold G Vulto, et al.Journal of Pharmaceutical Policy and Practice|June 23, 2021
Knowledge and perception of biosimilars in ambulatory care: a survey among Belgian community pharmacists and physiciansLiese Barbier, Yannick Vandenplas, Steven Simoens, et al.British Journal of Cancer|July 2, 2019
The arrival of biosimilar monoclonal antibodies in oncology: clinical studies for trastuzumab biosimilarsLiese Barbier, Paul Declerck, Steven Simoens, et al.Pageof 12